Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Amy Summy Biography and Net Worth

CMO of Laboratory Co. of America

Amy B. Summy serves as Executive Vice President, Chief Marketing Officer of the Company. Amy B. Summy has served as Executive Vice President and Chief Marketing Officer since March 2, 2020. Prior to joining LabCorp, she was Partner, Marketing & Insights Practice Leader for the Americas for Ernst & Young from February 2018 to February 2020. From January 2013 to January 2018, Ms. Summy was Senior Vice President and Chief Marketing Officer for TE Connectivity Ltd., where she built the marketing organization, establishing a digitally centered, customer-driven marketing capability for the company. Prior to that, Ms. Summy was Senior Vice President from July 2011 to December 2012. Ms. Summy also worked for Sapient and SapientNitro from 1996 to 2011, where she held executive agency leadership roles including Managing Director and Chief Marketing Officer. Ms. Summy received her Bachelor’s degree in Finance from Kent State University and holds a Master’s degree in Business Administration from New York University’s Stern School of Business. Ms. Summy co-founded and is a Board Member for No More Kids with Cancer, a childhood cancer research nonprofit dedicated to accelerating the discovery of safer, less toxic and more effective treatments for children with cancer.

What is Amy B. Summy's net worth?: The estimated net worth of Amy B. Summy is at least $826,482.00 as of April 1st, 2024. Ms. Summy owns 3,975 shares of Laboratory Co. of America stock worth more than $826,482 as of April 23rd. This net worth evaluation does not reflect any other assets that Ms. Summy may own. Learn More about Amy B. Summy's net worth.
How old is Amy B. Summy?: Ms. Summy is currently 57 years old. There are 8 older executives and no younger executives at Laboratory Co. of America. The oldest executive at Laboratory Co. of America is Dr. Marcia T. Eisenberg Ph.D., Chief Scientific Officer & Senior VP, who is 64 years old. Learn More on Amy B. Summy's age.
How do I contact Amy B. Summy?: The corporate mailing address for Ms. Summy and other Laboratory Co. of America executives is 358 South Main Street, BURLINGTON NC, 27215. Laboratory Co. of America can also be reached via phone at (336) 229-1127 and via email at [email protected]. Learn More on Amy B. Summy's contact information.
Has Amy B. Summy been buying or selling shares of Laboratory Co. of America?: Within the last three months, Amy B. Summy has sold $760,515.00 in shares of Laboratory Co. of America stock. Most recently, Amy B. Summy sold 3,500 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $217.29, for a transaction totalling $760,515.00. Following the completion of the sale, the chief marketing officer now directly owns 3,975 shares of the company's stock, valued at $863,727.75. Learn More on Amy B. Summy's trading history.
Who are Laboratory Co. of America's active insiders?: Laboratory Co. of America's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Brian Caveney (EVP), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Laboratory Co. of America's active insiders.
Are insiders buying or selling shares of Laboratory Co. of America?: During the last year, insiders at the medical research company sold shares 14 times. They sold a total of 66,701 shares worth more than $14,419,280.01. The most recent insider tranaction occured on April, 1st when COO Mark S Schroeder sold 6,477 shares worth more than $1,407,387.33. Insiders at Laboratory Co. of America own 0.9% of the company. Learn More about insider trades at Laboratory Co. of America.
Information on this page was last updated on 4/1/2024.

Amy B. Summy Insider Trading History at Laboratory Co. of America

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2024	Sell	3,500	$217.29	$760,515.00	3,975
3/7/2024	Sell	227	$218.45	$49,588.15	3,859
3/10/2022	Sell	249	$262.21	$65,290.29

Amy B. Summy Buying and Selling Activity at Laboratory Co. of America

Laboratory Co. of America Company Overview

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Today's Range

Now: $207.92

$204.31

$210.63

50 Day Range

MA: $213.25

$199.44

$228.11

2 Week Range

Now: $207.92

$174.20

$234.09

Volume

925,306 shs

Average Volume

738,850 shs

Market Capitalization

$17.49 billion

P/E Ratio

44.52

Dividend Yield

1.43%

Beta

1.01

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad